Two Sigma Advisers’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $583K | Sell |
|
|||||
|
2025
Q1 | $754K | Sell |
|
|||||
|
2024
Q4 | $1.06M | Buy |
|
|||||
|
2024
Q3 | $627K | Buy |
|
|||||
|
2024
Q2 | $282K | Sell |
|
|||||
|
2024
Q1 | $922K | Sell |
|
|||||
|
2023
Q4 | $955K | Sell |
|
|||||
|
2023
Q3 | $1.11M | Sell |
|
|||||
|
2023
Q2 | $2.83M | Sell |
|
|||||
|
2023
Q1 | $3.12M | Buy |
|
|||||
|
2022
Q4 | $2.7M | Sell |
|
|||||
|
2022
Q3 | $2.3M | Buy |
|
|||||
|
2022
Q2 | $357K | Buy |
|
|||||
|
2022
Q1 | $155K | Sell |
|
|||||
|
2021
Q4 | $1.5M | Sell |
|
|||||
|
2021
Q3 | $6.59M | Sell |
|
|||||
|
2021
Q2 | $8.29M | Sell |
|
|||||
|
2021
Q1 | $8.1M | Buy |
|
|||||
|
2020
Q4 | $1.26M | Sell |
|
|||||
|
2020
Q3 | $2.48M | Buy |
|
|||||
|
2020
Q2 | $1.57M | Buy |
|
|||||
|
2020
Q1 | $1.26M | Buy |
|
|||||
|
2019
Q4 | $1.68M | Buy |
|
|||||
|
2019
Q3 | $1.25M | Buy |
|
|||||
|
2019
Q2 | $1.47M | Buy |
|
|||||
|
2019
Q1 | $1.32M | Buy |
|
|||||
|
2018
Q4 | $398K | Sell |
|
|||||
|
2018
Q3 | $671K | Buy |
|
|||||
|
2018
Q2 | $447K | Buy |
|
|||||
|
2018
Q1 | $521K | Buy |
|
|||||
|
2017
Q4 | $399K | Buy |
|
|||||
|
2017
Q3 | $200K | Sell |
|
|||||
|
2017
Q2 | $255K | Sell |
|
|||||
|
2017
Q1 | $337K | Sell |
|
|||||
|
2016
Q4 | $474K | Sell |
|
|||||
|
2016
Q3 | $1M | Buy |
|
|||||
|
2016
Q2 | $539K | Sell |
|
|||||
|
2016
Q1 | $585K | Sell |
|
|||||
|
2015
Q4 | $867K | Sell |
|
|||||
|
2015
Q3 | $790K | Sell |
|
|||||
|
2015
Q2 | $1.11M | Buy |
|
|||||
|
2015
Q1 | $1.02M | Buy |
|
|||||
|
2014
Q4 | $585K | Buy |
|
|||||
|
2014
Q3 | $444K | Sell |
|
|||||
|
2014
Q2 | $868K | Buy |
|
|||||
|
2014
Q1 | $863K | Sell |
|
|||||
|
2013
Q4 | $672K | Buy |
|